{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:48:43Z","timestamp":1789170523172,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Raagholtstiftelsen"},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2017076"],"award-info":[{"award-number":["2017076"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A diagnosis of primary sclerosing cholangitis (PSC) has been associated with increased risk of hepatobiliary cancers, colorectal cancer and all-cause mortality in several studies, while associations with cardiovascular disease have been inconsistent. We conducted a systematic review and meta-analysis of published cohort studies on the topic to summarize these associations. PubMed and Embase databases were searched up to January 13th, 2020. Cohort studies on PSC and risk of cancer, cardiovascular disease, or mortality were included. Summary relative risks (RRs) and 95% confidence intervals (95% CIs) were estimated using random effects models. The summary RR (95% CI) comparing persons with PSC to persons without PSC was 584.37 (269.42\u20131267.51, I<jats:sup>2<\/jats:sup>\u2009=\u200989%, n\u2009=\u20094) for cholangiocarcinoma (CCA), 155.54 (125.34\u2013193.02, I<jats:sup>2<\/jats:sup>\u2009=\u20090%, n\u2009=\u20093) for hepatobiliary cancer, 30.22 (11.99\u201376.17, I<jats:sup>2<\/jats:sup>\u2009=\u20090%, n\u2009=\u20092) for liver cancer, 16.92 (8.73\u201332.78, I<jats:sup>2<\/jats:sup>\u2009=\u200988%, n\u2009=\u20094) for gastrointestinal cancer, 7.56 (2.42\u201323.62, I<jats:sup>2<\/jats:sup>\u2009=\u20090%, n\u2009=\u20093) for pancreatic cancer, 6.10 (4.19\u20138.87, I<jats:sup>2<\/jats:sup>\u2009=\u200914%, n\u2009=\u20097) for colorectal cancer (CRC), 4.13 (2.99\u20135.71, I<jats:sup>2<\/jats:sup>\u2009=\u200980%, n\u2009=\u20095) for total cancer, 3.55 (2.94\u20134.28, I<jats:sup>2<\/jats:sup>\u2009=\u200946%, n\u2009=\u20095) for all-cause mortality, and 1.57 (0.25\u20139.69, I<jats:sup>2<\/jats:sup>\u2009=\u200979%, n\u2009=\u20092) for cardiovascular disease. Strong positive associations were observed between PSC and risk of CCA, hepatobiliary cancer, liver cancer, gastrointestinal cancer, pancreatic cancer, CRC, total cancer, and all-cause mortality, but not for cardiovascular disease.<\/jats:p>","DOI":"10.1038\/s41598-021-90175-w","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T10:03:08Z","timestamp":1621504988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Primary sclerosing cholangitis and the risk of cancer, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of cohort studies"],"prefix":"10.1038","volume":"11","author":[{"given":"Dagfinn","family":"Aune","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Norat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Riboli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine","family":"Folseraas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"90175_CR1","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","volume":"382","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield, G. M., Karlsen, T. H., Lindor, K. D. & Adams, D. H. Primary sclerosing cholangitis. Lancet 382, 1587\u20131599 (2013).","journal-title":"Lancet"},{"key":"90175_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.jhep.2008.02.017","volume":"48","author":"TR Card","year":"2008","unstructured":"Card, T. R., Solaymani-Dodaran, M. & West, J. Incidence and mortality of primary sclerosing cholangitis in the UK: A population-based cohort study. J. Hepatol. 48, 939\u2013944 (2008).","journal-title":"J. Hepatol."},{"key":"90175_CR3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/ng.2616","volume":"45","author":"JZ Liu","year":"2013","unstructured":"Liu, J. Z. et al. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat. Genet. 45, 670\u2013675 (2013).","journal-title":"Nat. Genet."},{"key":"90175_CR4","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.cgh.2013.09.024","volume":"12","author":"IM Andersen","year":"2014","unstructured":"Andersen, I. M. et al. Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis. Clin. Gastroenterol. Hepatol. 12, 1019\u20131028 (2014).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"90175_CR5","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.cgh.2013.12.036","volume":"12","author":"C Lammert","year":"2014","unstructured":"Lammert, C. et al. Reduced coffee consumption among individuals with primary sclerosing cholangitis but not primary biliary cirrhosis. Clin. Gastroenterol. Hepatol. 12, 1562\u20131568 (2014).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"90175_CR6","unstructured":"World Cancer Research Fund & American Institute for Cancer Research. Diet, nutrition, physical activity and cancer: A global perspective. The Third Expert Report. (2018)."},{"key":"90175_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/liv.12894","volume":"36","author":"K Boonstra","year":"2016","unstructured":"Boonstra, K. et al. Risk factors for primary sclerosing cholangitis. Liver Int. 36, 84\u201391 (2016).","journal-title":"Liver Int."},{"key":"90175_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/MEG.0000000000000747","volume":"29","author":"M Fraga","year":"2017","unstructured":"Fraga, M. et al. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: Prevalence, risk factors, and long-term follow-up. Eur. J. Gastroenterol. Hepatol. 29, 91\u201397 (2017).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"90175_CR9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/gut.51.4.567","volume":"51","author":"SA Mitchell","year":"2002","unstructured":"Mitchell, S. A. et al. Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: A case control study. Gut 51, 567\u2013573 (2002).","journal-title":"Gut"},{"key":"90175_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","volume":"99","author":"K Burak","year":"2004","unstructured":"Burak, K. et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am. J. Gastroenterol. 99, 523\u2013526 (2004).","journal-title":"Am. J. Gastroenterol."},{"key":"90175_CR11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1478-3231.2011.02614.x","volume":"32","author":"MB de Valle","year":"2012","unstructured":"de Valle, M. B., Bjornsson, E. & Lindkvist, B. Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort. Liver Int. 32, 441\u2013448 (2012).","journal-title":"Liver Int."},{"key":"90175_CR12","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/hep.26565","volume":"58","author":"K Boonstra","year":"2013","unstructured":"Boonstra, K. et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 58, 2045\u20132055 (2013).","journal-title":"Hepatology"},{"key":"90175_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00365521.2019.1707277","volume":"55","author":"N Barner-Rasmussen","year":"2020","unstructured":"Barner-Rasmussen, N., Pukkala, E., Jussila, A. & Farkkila, M. Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: A population-based study in Finland. Scand. J. Gastroenterol. 55, 1\u20138 (2020).","journal-title":"Scand. J. Gastroenterol."},{"key":"90175_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","volume":"36","author":"A Bergquist","year":"2002","unstructured":"Bergquist, A. et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J. Hepatol. 36, 321\u2013327 (2002).","journal-title":"J. Hepatol."},{"key":"90175_CR15","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/hep.24743","volume":"55","author":"JH Ngu","year":"2012","unstructured":"Ngu, J. H., Gearry, R. B., Frampton, C. M. & Stedman, C. A. Mortality and the risk of malignancy in autoimmune liver diseases: A population-based study in Canterbury, New Zealand. Hepatology 55, 522\u2013529 (2012).","journal-title":"Hepatology"},{"key":"90175_CR16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/gutjnl-2013-305039","volume":"63","author":"KK Sogaard","year":"2014","unstructured":"Sogaard, K. K., Erichsen, R., Lund, J. L., Farkas, D. K. & Sorensen, H. T. Cholangitis and subsequent gastrointestinal cancer risk: A Danish population-based cohort study. Gut 63, 356\u2013361 (2014).","journal-title":"Gut"},{"key":"90175_CR17","doi-asserted-by":"publisher","first-page":"e7116","DOI":"10.1097\/MD.0000000000007116","volume":"96","author":"H Liang","year":"2017","unstructured":"Liang, H., Manne, S., Shick, J., Lissoos, T. & Dolin, P. Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom. Medicine (Baltimore) 96, e7116 (2017).","journal-title":"Medicine (Baltimore)"},{"key":"90175_CR18","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1053\/gast.1996.v110.pm8566590","volume":"110","author":"EV Loftus Jr","year":"1996","unstructured":"Loftus, E. V. Jr. et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology 110, 432\u2013440 (1996).","journal-title":"Gastroenterology"},{"key":"90175_CR19","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jhep.2013.11.017","volume":"60","author":"JF Ludvigsson","year":"2014","unstructured":"Ludvigsson, J. F., Bergquist, A., Montgomery, S. M. & Bahmanyar, S. Risk of diabetes and cardiovascular disease in patients with primary sclerosing cholangitis. J. Hepatol. 60, 802\u2013808 (2014).","journal-title":"J. Hepatol."},{"key":"90175_CR20","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher, D., Liberati, A., Tetzlaff, J. & Altman, D. G. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 339, b2535 (2009).","journal-title":"BMJ"},{"key":"90175_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin. Trials 7, 177\u2013188 (1986).","journal-title":"Control Clin. Trials"},{"key":"90175_CR22","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539\u20131558 (2002).","journal-title":"Stat. Med."},{"key":"90175_CR23","unstructured":"Wells, G., et al. The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http:\/\/www.ohrica\/programs\/clinical_epidemiology\/oxfordasp, Accessed 09 Aug 2018."},{"key":"90175_CR24","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger, M., Davey, S. G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629\u2013634 (1997).","journal-title":"BMJ"},{"key":"90175_CR25","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg, C. B. & Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088\u20131101 (1994).","journal-title":"Biometrics"},{"key":"90175_CR26","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","volume":"152","author":"TJ Weismuller","year":"2017","unstructured":"Weismuller, T. J. et al. Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis. Gastroenterology 152, 1975\u20131984 (2017).","journal-title":"Gastroenterology"},{"key":"90175_CR27","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","volume":"19","author":"MW Lutgens","year":"2013","unstructured":"Lutgens, M. W. et al. Declining risk of colorectal cancer in inflammatory bowel disease: An updated meta-analysis of population-based cohort studies. Inflamm. Bowel Dis. 19, 789\u2013799 (2013).","journal-title":"Inflamm. Bowel Dis."},{"key":"90175_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/MEG.0000000000000576","volume":"28","author":"HH Zheng","year":"2016","unstructured":"Zheng, H. H. & Jiang, X. L. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: A meta-analysis of 16 observational studies. Eur. J. Gastroenterol. Hepatol. 28, 383\u2013390 (2016).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"90175_CR29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1053\/gast.2001.20875","volume":"120","author":"M Jaiswal","year":"2001","unstructured":"Jaiswal, M., LaRusso, N. F., Shapiro, R. A., Billiar, T. R. & Gores, G. J. Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. Gastroenterology 120, 190\u2013199 (2001).","journal-title":"Gastroenterology"},{"key":"90175_CR30","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1053\/gast.2002.36021","volume":"123","author":"M Taniai","year":"2002","unstructured":"Taniai, M., Higuchi, H., Burgart, L. J. & Gores, G. J. p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma. Gastroenterology 123, 1090\u20131098 (2002).","journal-title":"Gastroenterology"},{"key":"90175_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/ng0196-97","volume":"12","author":"L Zuo","year":"1996","unstructured":"Zuo, L. et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat. Genet. 12, 97\u201399 (1996).","journal-title":"Nat. Genet."},{"key":"90175_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0065-230X(08)60352-8","volume":"68","author":"M Hall","year":"1996","unstructured":"Hall, M. & Peters, G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res. 68, 67\u2013108 (1996).","journal-title":"Adv. Cancer Res."},{"key":"90175_CR33","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/(SICI)1097-0215(19961220)69:6<466::AID-IJC8>3.0.CO;2-2","volume":"69","author":"Y Ichikawa","year":"1996","unstructured":"Ichikawa, Y. et al. Inactivation of p16\/CDKN2 and p15\/MTS2 genes in different histological types and clinical stages of primary ovarian tumors. Int. J. Cancer 69, 466\u2013470 (1996).","journal-title":"Int. J. Cancer"},{"key":"90175_CR34","first-page":"1137","volume":"56","author":"L Huang","year":"1996","unstructured":"Huang, L. et al. Deletion and mutation analyses of the P16\/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas. Cancer Res. 56, 1137\u20131141 (1996).","journal-title":"Cancer Res."},{"key":"90175_CR35","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/ng1095-210","volume":"11","author":"P Cairns","year":"1995","unstructured":"Cairns, P. et al. Frequency of homozygous deletion at p16\/CDKN2 in primary human tumours. Nat. Genet. 11, 210\u2013212 (1995).","journal-title":"Nat. Genet."},{"key":"90175_CR36","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0016-5085(99)70137-X","volume":"116","author":"Y Matsuda","year":"1999","unstructured":"Matsuda, Y., Ichida, T., Matsuzawa, J., Sugimura, K. & Asakura, H. p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology 116, 394\u2013400 (1999).","journal-title":"Gastroenterology"},{"key":"90175_CR37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/1097-0142(20000701)89:1<60::AID-CNCR9>3.0.CO;2-3","volume":"89","author":"M Jin","year":"2000","unstructured":"Jin, M. et al. p16 is a major inactivation target in hepatocellular carcinoma. Cancer 89, 60\u201368 (2000).","journal-title":"Cancer"},{"key":"90175_CR38","first-page":"1767","volume":"151","author":"AK El-Naggar","year":"1997","unstructured":"El-Naggar, A. K. et al. Methylation, a major mechanism of p16\/CDKN2 gene inactivation in head and neck squamous carcinoma. Am. J. Pathol. 151, 1767\u20131774 (1997).","journal-title":"Am. J. Pathol."},{"key":"90175_CR39","first-page":"4525","volume":"55","author":"JG Herman","year":"1995","unstructured":"Herman, J. G. et al. Inactivation of the CDKN2\/p16\/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55, 4525\u20134530 (1995).","journal-title":"Cancer Res."},{"key":"90175_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1242\/dmm.010561","volume":"6","author":"A Zabron","year":"2013","unstructured":"Zabron, A., Edwards, R. J. & Khan, S. A. The challenge of cholangiocarcinoma: Dissecting the molecular mechanisms of an insidious cancer. Dis. Model Mech. 6, 281\u2013292 (2013).","journal-title":"Dis. Model Mech."},{"key":"90175_CR41","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1053\/jhep.2002.34435","volume":"36","author":"K Endo","year":"2002","unstructured":"Endo, K., Yoon, B. I., Pairojkul, C., Demetris, A. J. & Sirica, A. E. ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions. Hepatology 36, 439\u2013450 (2002).","journal-title":"Hepatology"},{"key":"90175_CR42","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1007\/s00018-017-2472-6","volume":"74","author":"EJ Andress","year":"2017","unstructured":"Andress, E. J., Nicolaou, M., McGeoghan, F. & Linton, K. J. ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population. Cell Mol. Life Sci. 74, 2513\u20132524 (2017).","journal-title":"Cell Mol. Life Sci."},{"key":"90175_CR43","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/liv.12640","volume":"35","author":"E von Seth","year":"2015","unstructured":"von Seth, E., Arnelo, U., Enochsson, L. & Bergquist, A. Primary sclerosing cholangitis increases the risk for pancreatitis after endoscopic retrograde cholangiopancreatography. Liver Int. 35, 254\u2013262 (2015).","journal-title":"Liver Int."},{"key":"90175_CR44","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/ajg.2017.218","volume":"112","author":"J Kirkegard","year":"2017","unstructured":"Kirkegard, J., Mortensen, F. V. & Cronin-Fenton, D. Chronic pancreatitis and pancreatic cancer risk: A systematic review and meta-analysis. Am. J. Gastroenterol. 112, 1366\u20131372 (2017).","journal-title":"Am. J. Gastroenterol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90175-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90175-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90175-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T07:31:37Z","timestamp":1725089497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90175-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["90175"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-90175-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,20]]},"assertion":[{"value":"3 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10646"}}